David Carmel

Chief Growth and Innovation Officer

Professional Overview
David Carmel is an accomplished life sciences executive with extensive experience in driving growth, innovation, and strategic initiatives. As the Chief Growth and Innovation Officer at the Foundation for the National Institutes of Health, he leverages his deep industry expertise and entrepreneurial mindset to catalyze advancements in the biomedical research ecosystem.

Experience Summary

Current Role
In his current role, David is responsible for spearheading the foundation's strategic growth initiatives, fostering public-private partnerships, and cultivating a culture of innovation. He works closely with the NIH leadership to identify and implement transformative programs that accelerate the translation of scientific discoveries into tangible patient and societal benefits.

Career Progression
Prior to his current position, David held senior leadership roles at several leading life sciences organizations. As the Senior Vice President of Public Affairs and Communications at eGenesis, Inc., he played a pivotal role in shaping the company's public narrative and advancing its mission to address the global organ shortage. At Atara Biotherapeutics, he served as Vice President, where he led cross-functional teams in the development and commercialization of novel cell therapies. Earlier in his career, David founded Jumpstart, a successful technology startup, and served as a White House Fellow at the U.S. Department of Treasury, further demonstrating his entrepreneurial spirit and commitment to public service.

Academic Background
David holds a Bachelor's degree from Harvard University, where he graduated with high honors. His academic achievements and specialized training in business, finance, and public policy have provided him with a well-rounded perspective that he applies to his work in the life sciences industry.

Areas of Expertise

• Growth strategy and business development

• Public-private partnerships and collaborations

• Regulatory navigation and stakeholder engagement

• Cell and gene therapy commercialization

• Entrepreneurship and innovation management

Professional Impact
Throughout his career, David has made significant contributions to the life sciences industry. At eGenesis, he led the development and implementation of a comprehensive public affairs strategy that positioned the company as a leader in the field of xenotransplantation. At Atara Biotherapeutics, he spearheaded the successful launch of a groundbreaking cell therapy product, positively impacting the lives of patients suffering from rare and severe medical conditions.

Conclusion
David Carmel's diverse background, strategic vision, and passion for innovation make him a valuable asset to the Foundation for the National Institutes of Health. As the Chief Growth and Innovation Officer, he is poised to drive transformative change and accelerate the translation of cutting-edge biomedical research into life-changing solutions for patients worldwide.